Elad Amor
Comptroller/Controller/Auditor bij MOTUS GI HOLDINGS, INC.
Vermogen: - $ op 31-05-2024
Profiel
Elad Amor is currently the Chief Accounting Officer at Motus GI Holdings, Inc. He previously worked as the Director-Accounting & Section Reporting at Kaleido Biosciences, Inc. and as the Manager-SEC Reporting & Technical Accounting at CRISPR Therapeutics AG.
Mr. Amor holds a graduate degree in MBA from Northeastern University and undergraduate degrees from the University of Wisconsin.
He also has a graduate degree from The Medical College of Wisconsin, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MOTUS GI HOLDINGS, INC.
-.--% | 17-06-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Elad Amor
| Bedrijven | Functie | Begin |
|---|---|---|
| MOTUS GI HOLDINGS, INC. | Comptroller/Controller/Auditor | 01-01-2019 |
Eerdere bekende functies van Elad Amor
| Bedrijven | Functie | Einde |
|---|---|---|
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01-01-2019 |
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | - |
Opleiding van Elad Amor
| Northeastern University | Graduate Degree |
| The Medical College of Wisconsin, Inc. | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MOTUS GI HOLDINGS, INC. | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
